279 related articles for article (PubMed ID: 22511313)
1. Early phase clinical trials in pediatric hematology and oncology.
Corbacioglu S
Klin Padiatr; 2012 Apr; 224(3):197-200. PubMed ID: 22511313
[TBL] [Abstract][Full Text] [Related]
2. [Clinical studies in oncology--a challenge for clinical and academic pathology].
Röcken C
Dtsch Med Wochenschr; 2013 May; 138(20):1073-6. PubMed ID: 23670265
[No Abstract] [Full Text] [Related]
3. [Complementary medicine as political process. Swiss public opinion on the "Future with Complementary Medicine"].
Rist L; Schwabl H
Forsch Komplementmed; 2009 Apr; 16(2):76-8. PubMed ID: 19420952
[No Abstract] [Full Text] [Related]
4. [Individualized (personalized) treatment - now in rehabilitation, too?].
Reuss-Borst MA
Dtsch Med Wochenschr; 2013 Apr; 138(17):879. PubMed ID: 23592343
[No Abstract] [Full Text] [Related]
5. [Drug development in paediatric oncology].
Benninger-Döring G; Boos J
Klin Padiatr; 2006; 218(3):152-6. PubMed ID: 16688671
[TBL] [Abstract][Full Text] [Related]
6. Making the investigational oncology pipeline more efficient and effective: are we headed in the right direction?
LoRusso PM; Anderson AB; Boerner SA; Averbuch SD
Clin Cancer Res; 2010 Dec; 16(24):5956-62. PubMed ID: 21169248
[TBL] [Abstract][Full Text] [Related]
7. A decision analytic approach to a futility analysis of a phase II pharmaceutical study.
Pallay A
J Biopharm Stat; 2001 Nov; 11(4):209-25. PubMed ID: 12018776
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic targets, magnitude of benefit, and market pricing of antineoplastic drugs.
Amir E; Seruga B; Martinez-Lopez J; Kwong R; Pandiella A; Tannock IF; Ocaña A
J Clin Oncol; 2011 Jun; 29(18):2543-9. PubMed ID: 21606435
[TBL] [Abstract][Full Text] [Related]
9. [Hospital network in pediatric oncology].
Doz F
Arch Pediatr; 2006 Jun; 13(6):635-7. PubMed ID: 16697587
[No Abstract] [Full Text] [Related]
10. Children's clinical cancer trials: what needs to change to allow children access to new cancer drugs?
Moreno L; Pearson AD
Expert Rev Clin Pharmacol; 2015; 8(6):665-7. PubMed ID: 26307367
[TBL] [Abstract][Full Text] [Related]
11. [The future of uro-oncology: what needs to be done to secure its place in the field of urology?].
Albers P; Gschwend J; Hakenberg O
Urologe A; 2011 Aug; 50(8):914-6. PubMed ID: 21735269
[TBL] [Abstract][Full Text] [Related]
12. [Is a jolt passing through oncology?].
Aumiller J
MMW Fortschr Med; 2006 May; 148(21):13-4. PubMed ID: 16796182
[No Abstract] [Full Text] [Related]
13. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
14. [New developments also in general medicine. GSK relies on research as well as transparent collaboration with physicians (interview by Dirk Einecke, Wolfgang van den Bergh, Peter Overbeck and Cornelius Heyer)].
Marshall CG; Strohmeyer T
MMW Fortschr Med; 2011 May; 153(21):10-1. PubMed ID: 21739676
[No Abstract] [Full Text] [Related]
15. Commentary on "European collaboration in trials of new agents for children with cancer" by Ablett et al.
Smith MA; Anderson BD
Eur J Cancer; 2004 Aug; 40(12):1893-5. PubMed ID: 15288292
[TBL] [Abstract][Full Text] [Related]
16. Era of personalized medicine may herald end of soaring cancer costs.
Keogh B
J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
[No Abstract] [Full Text] [Related]
17. Targeted immunotherapies overtaking emerging oncology market value based growth.
Jakovljevic MB
J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
[No Abstract] [Full Text] [Related]
18. The political evolution of mental health parity.
Barry CL
Harv Rev Psychiatry; 2006; 14(4):185-94. PubMed ID: 16912004
[TBL] [Abstract][Full Text] [Related]
19. [Future vascular medicine: inauguration of a cardiovascular hybrid concept].
Debus S; Larena-Avellaneda A; Kölbel T; Kieback A; Atlihan G; Diener H
Zentralbl Chir; 2014 Oct; 139(5):491-8. PubMed ID: 25313888
[TBL] [Abstract][Full Text] [Related]
20. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
